In EME,
we have been approaching Unmet medical needs with our technologies. We have six pipeline categories; solid cancer, cancer immunotherapies, infectious disease, respiratory disease, neurologic disease, and lifestyle related disease.
* June, 2023
- Solid Cancer
EME Code # Library Target Development Stage screening Optimization Pre-Clinical Trial Clinical Trial Hit* Lead* In vitro In vivo EME003 VHH Pancreatic Cancer 
EME005 VHH Breast Cancer EME006 VHH Liver Cancer EME014 VHH Pancreatic Cancer Esophageal Cancer
*Hit compound **Lead compound
* June, 2023
- Cancer Immunotherapy
EME Code # Library Target Development Stage screening Optimization Pre-Clinical Trial Clinical Trial Hit* Lead* In vitro In vivo EME018 VHH Immune Check point
*Hit compound **Lead compound
* June, 2023
- Infectious Disease
EME Code # Library Target Development Stage screening Optimization Pre-Clinical Trial Clinical Trial Hit* Lead* In vitro In vivo EME018 VHH Covid-19
*Hit compound **Lead compound
* June, 2023
- Respiratory Disease
EME Code # Library Target Development Stage screening Optimization Pre-Clinical Trial Clinical Trial Hit* Lead* In vitro In vivo EME020 VHH Asthma
*Hit compound **Lead compound
* June, 2023
- Neurologic Disease
EME Code # Library Target Development Stage screening Optimization Pre-Clinical Trial Clinical Trial Hit* Lead* In vitro In vivo EME023 VHH ALS Parkinson Disease
*Hit compound **Lead compound
* June, 2023
- Lifestyle related Disease
EME Code # Library Target Development Stage screening Optimization Pre-Clinical Trial Clinical Trial Hit* Lead* In vitro In vivo EME008 VHH NASH
*Hit compound **Lead compound
* June, 2023